Clearside Biomedical, Inc. (CLSD)
Q3 2019 Earnings Conference Call
November 06, 2019, 16:30 ET
Company Participants
Jenny Kobin - Head, IR
George Lasezkay - Interim CEO & Director
Thomas Ciulla - Chief Medical Officer
Charles Deignan - CFO
Conference Call Participants
Liana Moussatos - Wedbush Securities
Presentation
Operator
Greetings, and welcome to the Clearside Biomedical Third Quarter 2019 Financial Results and Corporate Update Conference Call. As a reminder, this conference call is being recorded. I would now like to introduce your host, Jenny Kobin, Clearside Investor Relations. Please go ahead.
Jenny Kobin
Good afternoon, everyone,